Variables in 2011 | Categories | Model A | Model B | Model C | Model D |
---|---|---|---|---|---|
OR (CI 95%) | OR (CI 95%) | OR (CI 95%) | OR (CI 95%) | ||
Gender | Women | 1 | 1 | 1 | 1 |
Men | 0.66 (0.56–0.78)* | 0.66 (0.56–0.77)* | 0.71 (0.61–0.84)* | 0.71 (0.60–0.83)* | |
Age | 75–79 | 1 | 1 | 1 | 1 |
80–84 | 1.07 (0.89–1.28) | 1.03 (0.86–1.23) | 1.00 (0.83–1.19) | 0.99 (0.83–1.19) | |
85–89 | 1.26 (1.03–1.55)* | 1.19 (0.97–1.47) | 1.14 (0.93–1.41) | 1.16 (0.87–1.56) | |
≥90 | 1.62 (1.23–2.14)* | 1.57 (1.19–2.08)* | 1.39 (1.05–1.85)* | 1.39 (1.05–1.85)* | |
Number of chronic conditions | 0 | Â | 1 | Â | 1 |
1 |  | 1.29 (0.92–1.81) |  | 1.14 (0.81–1.62) | |
2–4 |  | 1.68 (1.26–2.24)* |  | 1.16 (0.87–1.56) | |
5–7 |  | 2.82 (2.10–3.80)* |  | 1.42 (1.04–1.94)* | |
≥8 |  | 2.78 (1.94–3.99)* |  | 1.11 (0.76–1.62) | |
Polypharmacy | < 5 |  |  | 1 | 1 |
≥5 |  |  | 4.64 (3.96–5.44)* | 4.40 (3.72–5.22)* |